- Berkshire invests in JPMorgan, Oracle as Warren Buffett puts cash to work
- Global fund managers bought into October correction: BofAML survey
- Ujjivan Financial gains 10% on bonus hope
- YES Bank falls 7% as Ashok Chawla resigns as non-executive chairman
- Jet Airways hits two-month high; soars 60% since October
- Audit companies get a breather on FDI front from SC-appointed committee
|BSE: 500087||Sector: Health care|
|NSE: CIPLA||ISIN Code: INE059A01026|
|BSE 11:27 | 15 Nov||517.00||
|NSE 11:14 | 15 Nov||518.20||
|Mkt Cap.(Rs cr)||41,631|
|Mkt Cap.(Rs cr)||41631.43|
Cipla Ltd. (CIPLA) - Latest News & Headlines
8.28 am | 14 Nov 2018 | Business Standard
Acquisition to help the company build a specialty pipeline in the US
12.00 am | 7 Nov 2018 | Press Trust of India
At NSE, shares of the company dropped 5.87% to close at Rs 529.95
10.59 am | 6 Nov 2018 | Business Standard
The stock was down 5% at Rs 534, trading at its lowest level since June 6, 2018 on the BSE.
12.45 am | 6 Nov 2018 | Business Standard
Company cautious on prospects, given supply disruptions & commodity inflation, among others
9.44 pm | 5 Nov 2018 | Business Standard
Tender business, which accounts for around 20% of consolidated sales, came under pressure because of intense competition and aggressive pricing
2.53 pm | 5 Nov 2018 | Business Standard
The stock has dipped 8% to Rs 558 on the BSE after the pharmaceutical company posted 11% decline in its consolidated net profit at Rs 3.77 billion for...
10.31 am | 29 Oct 2018 | Business Standard
Cipla's Metoprolol ER Tablets 50mg, 100mg, 200mg is AB-rated beta1-selective adrenoceptor blocking agent
10.25 am | 15 Oct 2018 | Business Standard
Nifty Pharma index, the largest gainer among sectoral indices, was up 1.7% as compared to 0.17% decline in Nifty 50 index at 09:36 am.
10.16 pm | 9 Oct 2018 | Business Standard
In India, the company is by far the leader in the respiratory drugs segment, having a turnover of over Rs 18.93 billion
9.48 pm | 30 Sep 2018 | Business Standard
'We are looking to provide end-to-end solutions in the area of disease management for Patients'
10.37 am | 14 Sep 2018 | Business Standard
Sun Pharma rose over 3 per cent to an intra-day high of Rs 670.90 on the NSE after the drug maker announced USFDA approval of XELPROS to treat open-an...
9.00 am | 12 Sep 2018 | Business Standard
Sun Pharma said the US health regulator USFDA was conducting an inspection of its Mohali facility in Punjab.
3.21 pm | 6 Sep 2018 | Business Standard
Granules India, Hikal, Pfizer, Lincoln Pharmaceuticals, Astrazeneca Pharma India and Aarti Drugs were up between 4% and 7%.
10.20 am | 23 Aug 2018 | Business Standard
Nifty Pharma index hit a 52-week high of 10,142, rising 2%, in early morning deal, surpassing its previous high of 10,063 recorded on November 3, 2017...
11.22 pm | 8 Aug 2018 | Business Standard
Q1 net profit up 10 per cent, ties up for biosimilars in emerging markets
9.11 pm | 18 Jul 2018 | Business Standard
The company is looking at inorganic growth opportunities to offset delays in product approvals
3.25 pm | 3 Jul 2018 | Business Standard
At 02:43 pm; Nifty Pharma index, the largest gainer among sectoral indices, was up 2.3% as compared to 0.46% rise in the Nifty 50 index.
9.45 am | 20 Jun 2018 | Business Standard
The stock up 3% at Rs 622 on the BSE in early morning trade and is 6.6% away from its 52-week high of Rs 663 touched on November 7, 2017.
12.22 pm | 15 Jun 2018 | Business Standard
At 11:23 am; Nifty Pharma index, the largest gainer among sectoral indices, was up 2.2% at 9,310, surging 8.2% thus far in current week.